0,869  0,005  Antidiabetic
0,869  0,005  Cyclophilin D inhibitor
0,818  0,002  Protein-tyrosine phosphatase 1B inhibitor
0,817  0,002  Protein-tyrosine phosphatase inhibitor
0,798  0,003  Monophenol monooxygenase inhibitor
0,742  0,004  Skin whitener
0,708  0,005  Lipoxygenase inhibitor
0,718  0,028  Apoptosis agonist
0,702  0,020  Transcription factor NF kappa B inhibitor
0,658  0,011  Antineoplastic (ovarian cancer)
0,634  0,005  Antineoplastic (carcinoma)
0,629  0,009  Antioxidant
0,610  0,013  Chemopreventive
0,605  0,008  Free radical scavenger
0,603  0,010  AR expression inhibitor
0,540  0,005  Melanin inhibitor
0,535  0,014  Antineoplastic (multiple myeloma)
0,512  0,017  NOS2 expression inhibitor
0,509  0,038  Antibacterial
0,451  0,013  Antimutagenic
0,467  0,045  Antiprotozoal
0,447  0,027  UGT1A9 substrate
0,451  0,041  Prostate cancer treatment
0,468  0,062  Antineoplastic (breast cancer)
0,426  0,021  Amyloid beta aggregation inhibitor
0,432  0,030  Chemoprotective
0,422  0,023  Nitric oxide antagonist
0,398  0,004  Death-associated protein kinase 2 inhibitor
0,396  0,010  Lipid peroxidase inhibitor
0,410  0,061  Antileukemic
0,380  0,032  Antiamyloidogenic
0,355  0,009  Acetylcholinesterase inhibitor
0,381  0,036  Antineoplastic (non-small cell lung cancer)
0,383  0,057  Antineoplastic (colorectal cancer)
0,392  0,067  Antineoplastic (lung cancer)
0,360  0,039  Antiprotozoal (Leishmania)
0,375  0,055  Antineoplastic (colon cancer)
0,363  0,043  Antineoplastic (glioma)
0,366  0,051  12-Lipoxygenase inhibitor
0,389  0,079  15-Lipoxygenase inhibitor
0,303  0,004  Papain-like protease (SARS coronavirus) inhibitor
0,298  0,011  5-Lipoxygenase inhibitor
0,416  0,130  Antiinflammatory
0,338  0,053  Antiosteoporotic
0,345  0,063  Streptokinase A inhibitor
0,345  0,064  ICAM1 expression inhibitor
0,336  0,057  Cardioprotectant
0,339  0,063  Caspase 3 stimulant
0,289  0,015  Cyclooxygenase 1 inhibitor
0,322  0,063  Antineoplastic (melanoma)
0,283  0,024  UGT1A3 substrate
0,318  0,067  Antineoplastic (brain cancer)
0,324  0,076  Bone diseases treatment
0,318  0,072  Antifungal
0,255  0,012  Antihemorrhagic
0,294  0,054  Antineoplastic (renal cancer)
0,265  0,025  Cholinergic
0,278  0,041  UDP-glucuronosyltransferase substrate
0,259  0,025  NOS3 expression enhancer
0,366  0,133  Caspase 9 stimulant
0,299  0,067  Radioprotector
0,283  0,058  Proliferative diseases treatment
0,258  0,044  UGT1A1 substrate
0,325  0,111  Histamine release inhibitor
0,263  0,050  Antihypertriglyceridemic
0,301  0,098  Antiprotozoal (Plasmodium)
0,227  0,024  MAO A inhibitor
0,258  0,058  UGT1A6 substrate
0,213  0,017  Xanthine oxidase inhibitor
0,227  0,034  MAO inhibitor
0,198  0,007  Peroxisome proliferator-activated receptor gamma agonist
0,254  0,068  Angiogenesis stimulant
0,256  0,074  Hypoglycemic
0,267  0,085  Hypoxia-inducible factor 1 alpha inhibitor
0,224  0,045  Mcl-1 antagonist
0,262  0,085  CYP2C19 substrate
0,254  0,077  Antihypercholesterolemic
0,240  0,072  Hypolipemic
0,219  0,054  P-glycoprotein inhibitor
0,250  0,090  Lipoprotein disorders treatment
0,165  0,008  Phosphatidylinositol 3-kinase gamma inhibitor
0,174  0,017  Estrogen antagonist
0,227  0,071  Antineoplastic (glioblastoma multiforme)
0,213  0,058  Hepatoprotectant
0,255  0,100  NOS3 expression inhibitor
0,207  0,051  Dual specificity phosphatase inhibitor
0,160  0,012  HIV-1 integrase (3'-Processing) inhibitor
0,263  0,115  Apoptosis antagonist
0,153  0,006  Sirtuin 1 inhibitor
0,183  0,039  SULT1A3 substrate
0,173  0,033  Farnesoid X receptor antagonist
0,158  0,021  Breast cancer-resistant protein inhibitor
0,149  0,013  HIV-1 integrase (Strand Transfer) inhibitor
0,164  0,028  Antineoplastic antibiotic
0,150  0,015  Estrogen receptor beta antagonist
0,181  0,048  Antineoplastic (squamous cell carcinoma)
0,278  0,145  TNF expression inhibitor
0,160  0,030  Butyrylcholinesterase inhibitor
0,244  0,115  CTGF expression inhibitor
0,217  0,091  Vasodilator
0,138  0,014  Estrogen receptor alpha antagonist
0,132  0,008  Ca(v)3.1 blocker
0,176  0,054  UGT2B9 substrate
0,169  0,047  Histone deacetylase SIRT1 inhibitor
0,144  0,024  Electron transport complex I inhibitor
0,134  0,017  Ornithine decarboxylase inhibitor
0,171  0,056  Cyclooxygenase inhibitor
0,257  0,143  Immunosuppressant
0,122  0,009  Neuraminidase inhibitor
0,208  0,096  Antihypotensive
0,161  0,053  Tubulin antagonist
0,191  0,086  Neurotrophic factor enhancer
0,204  0,098  Antineoplastic (cervical cancer)
0,200  0,098  Antineoplastic (lymphocytic leukemia)
0,120  0,018  Lipase inhibitor
0,167  0,068  Arachidonic acid antagonist
0,110  0,014  Neuraminidase (influenza) inhibitor
0,114  0,019  Aromatase inhibitor
0,137  0,042  MAO B inhibitor
0,157  0,067  Heat shock protein 90 antagonist
0,169  0,081  Dual specificity phosphatase 3 inhibitor
0,126  0,041  Beta glucuronidase inhibitor
0,210  0,128  UGT2B4 substrate
0,098  0,017  Phosphatidylinositol 3-kinase alpha inhibitor
0,121  0,048  Multidrug resistance-associated protein 1 inhibitor
0,156  0,083  UGT2B7 substrate
0,089  0,020  Aldose reductase inhibitor
0,163  0,095  Antihelmintic
0,135  0,067  Death-associated protein kinase 1 inhibitor
0,108  0,040  SULT1E1 substrate
0,078  0,012  Glucose-6-phosphate translocase inhibitor
0,158  0,093  Amyloid beta precursor protein antagonist
0,195  0,131  Antineoplastic (pancreatic cancer)
0,071  0,016  Acetyl-CoA transferase 2 inhibitor
0,180  0,125  Cardiovascular analeptic
0,138  0,084  Antiviral (Influenza A)
0,125  0,073  Antineoplastic (uterine cancer)
0,186  0,134  Superoxide dismutase inhibitor
0,087  0,036  SULT1A2 substrate
0,191  0,140  Respiratory analeptic
0,100  0,049  Alpha 2d adrenoreceptor antagonist
0,080  0,034  Peroxisome proliferator-activated receptor gamma antagonist
0,107  0,061  Gout treatment
0,116  0,070  Topoisomerase II inhibitor
0,164  0,119  Pneumotoxic
0,135  0,092  Antidiarrheal
0,108  0,066  Chelator
0,061  0,019  Estradiol 17 beta-dehydrogenase inhibitor
0,068  0,027  Estrogen agonist
0,105  0,066  DOPA decarboxylase inhibitor
0,159  0,122  Antiparasitic
0,125  0,090  UGT2B15 substrate
0,110  0,076  DNA polymerase I inhibitor
0,042  0,010  Leukotriene B4 receptor 1 antagonist
0,092  0,061  ABCA1 expression enhancer
0,065  0,035  Xanthine dehydrogenase inhibitor
0,063  0,034  Sphingosine kinase inhibitor
0,117  0,088  Bone formation stimulant
0,076  0,048  CDC25A inhibitor
0,060  0,033  Postmenopausal disorders treatment
0,032  0,007  Leukotriene B4 receptor 2 antagonist
0,057  0,033  Alpha tubulin antagonist
0,226  0,202  Alpha-glucosidase inhibitor
0,042  0,020  Retinoid X receptor antagonist
0,056  0,034  Leukotriene B4 antagonist
0,066  0,048  Leukotriene synthesis inhibitor
0,052  0,036  Vanilloid 2 antagonist
0,035  0,020  Peroxisome proliferator-activated receptor delta antagonist
0,157  0,142  Antineoplastic enhancer
0,035  0,021  Retinoid X alpha receptor antagonist
0,140  0,127  Antiviral (Influenza)
0,057  0,044  Phosphatidylinositol kinase inhibitor
0,030  0,018  Poly(ADP-ribose) polymerase 2 inhibitor
0,125  0,114  Adenylate cyclase stimulant
0,130  0,120  Sensitization
0,084  0,074  Uric acid excretion stimulant
0,219  0,210  CYP2C19 inhibitor
0,146  0,138  Insulin sensitizer
0,060  0,056  Transcription factor RelA inhibitor
0,089  0,087  HDL-cholesterol increasing

